These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34883528)

  • 21. Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia.
    Pisanò CA; Mercatelli D; Mazzocchi M; Brugnoli A; Morella I; Fasano S; Zaveri NT; Brambilla R; O'Keeffe GW; Neubig RR; Morari M
    Br J Pharmacol; 2023 Apr; 180(7):927-942. PubMed ID: 34767639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).
    Kaye AD; Jones MR; Kaye AM; Ripoll JG; Jones DE; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
    Pain Physician; 2017 Feb; 20(2S):S111-S133. PubMed ID: 28226334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New concepts in opioid analgesia.
    Stein C
    Expert Opin Investig Drugs; 2018 Oct; 27(10):765-775. PubMed ID: 30148648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in targeting ion channels to treat chronic pain.
    Stevens EB; Stephens GJ
    Br J Pharmacol; 2018 Jun; 175(12):2133-2137. PubMed ID: 29878335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
    Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
    Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid receptor trafficking and interaction in nociceptors.
    Zhang X; Bao L; Li S
    Br J Pharmacol; 2015 Jan; 172(2):364-74. PubMed ID: 24611685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MOPr-DOPr heteromer: the meaning and possibility as novel therapeutic target for pain control].
    Fujita W
    Nihon Yakurigaku Zasshi; 2021; 156(3):134-138. PubMed ID: 33952839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioids for chronic non-cancer pain: a critical view from the other side of the pond.
    Fanelli G; Tölle TR; DE Andrés J; Häuser W; Allegri M; Montella S; Kress HG
    Minerva Anestesiol; 2016 Jan; 82(1):97-102. PubMed ID: 26173558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How environmental enrichment balances out neuroinflammation in chronic pain and comorbid depression and anxiety disorders.
    Kimura LF; Novaes LS; Picolo G; Munhoz CD; Cheung CW; Camarini R
    Br J Pharmacol; 2022 Apr; 179(8):1640-1660. PubMed ID: 34076891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of bisphosphonates in pain.
    Tzschentke TM
    Br J Pharmacol; 2021 May; 178(9):1973-1994. PubMed ID: 31347149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioids and the immune system - friend or foe.
    Plein LM; Rittner HL
    Br J Pharmacol; 2018 Jul; 175(14):2717-2725. PubMed ID: 28213891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPARs and pain.
    Okine BN; Gaspar JC; Finn DP
    Br J Pharmacol; 2019 May; 176(10):1421-1442. PubMed ID: 29679493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid Analgesics.
    Jamison RN; Mao J
    Mayo Clin Proc; 2015 Jul; 90(7):957-68. PubMed ID: 26141334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central metabolism as a potential origin of sex differences in morphine antinociception but not induction of antinociceptive tolerance in mice.
    Gabel F; Hovhannisyan V; Andry V; Goumon Y
    Br J Pharmacol; 2023 Apr; 180(7):843-861. PubMed ID: 34986502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P2X receptor channels in chronic pain pathways.
    Bernier LP; Ase AR; Séguéla P
    Br J Pharmacol; 2018 Jun; 175(12):2219-2230. PubMed ID: 28728214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of opioids on immune function in patients with cancer pain: from bench to bedside.
    Boland JW; Pockley AG
    Br J Pharmacol; 2018 Jul; 175(14):2726-2736. PubMed ID: 28593737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations.
    Kahan M; Wilson L; Mailis-Gagnon A; Srivastava A;
    Can Fam Physician; 2011 Nov; 57(11):1269-76, e419-28. PubMed ID: 22084456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Announcing the CDC guideline for prescribing opioids for chronic pain.
    Houry D; Baldwin G
    J Safety Res; 2016 Jun; 57():83-4. PubMed ID: 27178083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and emerging options to combat the opioid epidemic.
    Kominek C
    Am J Manag Care; 2018 May; 24(10 Suppl):S207-S214. PubMed ID: 29851450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.